Abstract: The present disclosure discloses a testing system, a battery production line, and a testing method. The testing system includes a control device and a test device. The test device includes at least two probe card adjustment assemblies. The control device is connected to the test device and configured to adjust the probe card adjustment assemblies according to an adjustment strategy, and drive the adjusted probe card adjustment assemblies to test the battery module currently to be tested. The adjustment strategy is determined based on current module information corresponding to the battery module and historical module information. The historical module information is the module information of a battery module tested last time. The technical solution provided by the embodiments of the present disclosure can quickly adjust the probe card adjustment assemblies to adapt to different battery modules.

Abstract: An inspection circuit includes a plurality of inspection devices and a plurality of pathway switching circuits. Input ends of the pathway switching circuits are respectively connected to different test lines. The test lines are connected to a test terminal corresponding to a battery cell under test. Output ends of the pathway switching circuits are respectively connected to the plurality of inspection devices. The pathway switching circuit is configured to connect, according to an inspection signal, an inspection device corresponding to the inspection signal and a test terminal corresponding to the battery cell under test. The inspection device is configured to obtain an inspection result of the battery cell under test.

Abstract: A test system comprises a test circuit board, a test device, a lower computer, and an upper computer. The test circuit board includes a test circuit, the test circuit comprising multiple main lines arranged side by side, one end of each of the main lines being used to connect with a positive electrode or a negative electrode of each battery cell of the battery module, and the other end of each of the main lines being connected with a first branch and a second branch. The lower computer controls a first branch connected to one of the main lines to be electrically conductive to a positive electrode of the test device and a second branch connected to another one of the main lines to be electrically conductive to a negative electrode of the test device. The upper computer controls the lower computer and reads parameter information for the test device.

Abstract: A cell model for in vitro evaluation of compound-induced skin sensitization and a constructing method therefor. The method for constructing the cell model comprises the steps of: designing and constructing an sgRNA expression vector based on CRISPR/Cas9 vector system; designing and constructing a homologous recombinant vector capable of knocking a reporter gene linked to a self-cleaving peptide sequence into a specific site of the expression frame of the HMOX1 gene; co-transfecting the homologous recombinant vector, an hCas9 plasmid and the sgRNA expression vector into a cell, and carrying out monoclonal expansion to obtain the cell model. The present invention obtains a HaCaT cell model in which a luciferase gene is knocked in before the stop codon of the HMOX1 gene by combination of CRISPR/CAS9 and a monoclonal cell technique. The cell model realizes synchronous expression of the luciferase gene and the HMOX1 gene, thereby effectively distinguishing sensitizing compounds from non-sensitizing compounds.

Abstract: A test tool includes an operating portion with a first end used for hand-holding, and a profiling connector adapted to a socket to be detected and plugged. An elastic probe is provided in a jack of the profiling connector, and the profiling connector is arranged at a second end of the operating portion opposite to the first end. The profiling connector is configured to be inserted into the socket by holding the operating portion with hand, with the elastic probe abutting against and electrically connected with a probe in the socket.

Abstract: A method for identifying element failure in capacitor banks is provided. Capacitor bank phase current is measured and a zero-sequence or negative-sequence current is calculated or measured. A three-phase voltage is measured from a three-phase bus voltage transformer and a zero-sequence voltage or negative-sequence voltage is calculated. A compensated unbalance current is calculated and compared to a predetermined acceptable range. A failure is identified where the compensated unbalance current is outside the predetermined acceptable range.

Abstract: A method for identifying element failure in capacitor banks is provided. Capacitor bank phase current is measured and a zero-sequence or negative-sequence current is calculated or measured. A three-phase voltage is measured from a three-phase bus voltage transformer and a zero-sequence voltage or negative-sequence voltage is calculated. A compensated unbalance current is calculated and compared to a predetermined acceptable range. A failure is identified where the compensated unbalance current is outside the predetermined acceptable range.

Abstract: A cell model for in vitro evaluation of compound-induced skin sensitization and a constructing method therefor. The method for constructing the cell model comprises the steps of: designing and constructing an sgRNA expression vector based on CRISPR/Cas9 vector system; designing and constructing a homologous recombinant vector capable of knocking a reporter gene linked to a self-cleaving peptide sequence into a specific site of the expression frame of the HMOX1 gene; co-transfecting the homologous recombinant vector, an hCas9 plasmid and the sgRNA expression vector into a cell, and carrying out monoclonal expansion to obtain the cell model. The present invention obtains a HaCaT cell model in which a luciferase gene is knocked in before the stop codon of the HMOX1 gene by combination of CRISPR/CAS9 and a monoclonal cell technique. The cell model realizes synchronous expression of the luciferase gene and the HMOX1 gene, thereby effectively distinguishing sensitizing compounds from non-sensitizing compounds.

Abstract: Methods, systems, and computer readable media for session based software defined networking (SDN) management are disclosed. According to one method, the method occurs at a policy engine. The method includes determining, using a session identifier, Third Generation Partnership Project (3GPP) session information associated with a user device. The method also includes generating, using the 3GPP session information, SDN policy information for SDN related traffic associated with the 3GPP session, wherein the SDN policy information is for providing a quality of service (QoS) for the SDN related traffic corresponding to a QoS associated with the 3GPP session information, wherein the SDN related traffic is correlated with the 3GPP session using a source address associated with the user device.

Abstract: Methods, systems, and computer readable media for session based software defined networking (SDN) managment are disclosed. According to one method, the method occurs at a policy engine. The method includes determining, using a session identifier, Third Generation Partnership Project (3GPP) session information associated with a user device. The method also includes generating, using the 3GPP session information, SDN policy information for SDN related traffic associated with the 3GPP session, wherein the SDN policy information is for providing a quality of service (QoS) for the SDN related traffic corresponding to a QoS associated with the 3GPP session information, wherein the SDN related traffic is correlated with the 3GPP session using a source address associated with the user device.